Skip to main content

Table 1 Baseline clinical characteristics of all participants

From: MicroRNA-320a-3p Signatures as a Satisfactory Predictor of Acute Coronary Syndrome and Attenuates Inflammation by Targeting X-Linked Inhibitor of Apoptosis Protein

Characteristics Control (n = 126) ACS patients (n = 139) P value
Age 51.40 ± 7.27 51.55 ± 6.60 0.854
Gender (female/male) 63/63 69/70 0.953
Smoking
 Yes 64 69 0.851
 No 62 70  
Drinking
 Yes 58 65 0.905
 No 68 74  
TC (mmol/L) 4.67 ± 0.47 4.74 ± 0.90 0.436
TG (mmol/L) 1.36 ± 0.56 1.37 ± 0.64 0.895
LDL (mmol/L) 2.52 ± 0.487 2.60 ± 0.57 0.163
HDL (mmol/L) 1.40 ± 0.60 1.29 ± 0.42 0.083
vWF (ng/mL) 4.55 ± 1.40 7.99 ± 1.71  < 0.001
H-FABP (ng/mL) 4.50 ± 1.33 22.04 ± 4.09  < 0.001
TNF-α (ng/L) 10.17 ± 3.13 25.93 ± 5.78  < 0.001
IL-1β (ng/L) 9.67 ± 4.77 27.52 ± 7.64  < 0.001
IL-6 (ng/L) 8.85 ± 4.24 28.00 ± 6.64  < 0.001
  1. Data are expressed as n or mean ± standard deviation
  2. ACS acute coronary syndrome; TC total cholesterol; TC triglyceride; HDL high-density lipoprotein; LDL low density lipoprotein; vWF von willebrand factor; H-FABP heart-type fatty acid-binding protein; TNF-α tumor necrosis factor alpha; IL-6 interleukin 6; IL-1β interleukin 1β